CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,445 | +7.7% | 56,904 | -21.5% | 0.00% | – |
| Q2 2023 | $25,475 | +34.2% | 72,453 | -21.0% | 0.00% | – |
| Q1 2023 | $18,985 | +18.8% | 91,712 | +202.7% | 0.00% | – |
| Q4 2022 | $15,984 | -99.2% | 30,301 | -90.1% | 0.00% | -100.0% |
| Q4 2020 | $1,935,000 | +2550.7% | 306,690 | +4410.8% | 0.00% | – |
| Q3 2018 | $73,000 | – | 6,799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
| 22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
| Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
| Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
| Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
| Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
| Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
| AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |